ADC announces RNAscope technology clinical study outcomes for HPV-connected head and neck cancers Advanced Cell Diagnostics, Inc. These outcomes will be provided today at the 100th annual meeting of USA & Canadian Academy of Pathology . The study included 211 mind and neck cancers from the oropharynx .23, p < 0.001 for overall survival and disease-particular survival), in comparison to HPV-negative tumors. Detecting transcriptionally active HPV in the tumor cells is crucial to establish its presence as clinically significant,' said Dr. James Lewis Jr. Of Washington University in St. Louis, the principal investigator in this collaborative research.Related StoriesNew results reveal association between colorectal cancer and melanoma medication treatmentStudy shows uncommon HER2 missense mutations usually do not spread breast cancer on the ownCrucial change in single DNA base predisposes children to aggressive form of tumor This support from our existing traders displays their enthusiasm for Allegro’s concentrate on early lung cancer detection, stated Michael D. Webb, President and CEO of Allegro Diagnostics. Approximately 300,000 bronchoscopic exams are performed each year, but the most the results are inconclusive.